首页 › 基金 › Soleus Capital Management, L.P. › RIGL
Soleus Capital Management, L.P. 对 RIGL 的持仓历史
RIGEL PHARMACEUTICALS INC · 医疗保健
Soleus Capital Management, L.P. 在 Q3 2026 的 13F 申报中披露持有 RIGL(RIGEL PHARMACEUTICALS INC)1,843,504 股,市值约 US$88.8M,约占其申报组合的 3.16%,在其申报持仓中市值排名第 7 位。 Soleus Capital Management, L.P. 最近 13 个申报季度中有 13 个季度披露了 RIGL 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Soleus Capital Management, L.P. 对 RIGL 的持仓演变
Soleus Capital Management, L.P. 于 Q3 2023 首次披露 RIGL 持仓:14,803,015 股(约 US$16.0M)。 该持仓在 Q3 2026 达到峰值 1,843,504 股,市值约 US$88.8M。 在 13 次申报中,Soleus Capital Management, L.P. 2 次增持、8 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 1,843,504 股、市值约 US$88.8M。 持仓曾出现大幅变动:Q2 2024 减持约 89% (随后一个季度股价上涨 97%)、Q1 2026 减持约 97% (随后一个季度股价上涨 45%)、Q2 2026 增持约 18335% (随后一个季度股价上涨 23%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 14.80M | $15.99M | 新进 |
| Q4 2023 | 9.44M | $13.69M | 减持 |
| Q1 2024 | 9.24M | $13.68M | 减持 |
| Q2 2024 | 1.04M | $8.58M | 减持 |
| Q3 2024 | 934.79K | $15.12M | 减持 |
| Q4 2024 | 1.13M | $19.02M | 增持 |
| Q1 2025 | 1.13M | $20.34M | 持有 |
| Q2 2025 | 658.14K | $12.33M | 减持 |
| Q3 2025 | 330.01K | $9.35M | 减持 |
| Q4 2025 | 300.03K | $12.85M | 减持 |
| Q1 2026 | 10.00K | $270.40K | 减持 |
| Q2 2026 | 1.84M | $72.12M | 增持 |
| Q3 2026 | 1.84M | $88.76M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 RIGL 与 13F 数据
RIGL(RIGEL PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 43 只申报持有 RIGL,申报仓位最大的包括:ARMISTICE CAPITAL, LLC (US$74.0M), CM Management, LLC (US$12.0M), GLOBEFLEX CAPITAL L P (US$5.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 RIGL 的基金
- ARMISTICE CAPITAL, LLC 1.54M 股 · $73.96M · Q3 2026
- CM Management, LLC 250.00K 股 · $12.04M · Q3 2026
- GLOBEFLEX CAPITAL L P 112.67K 股 · $5.43M · Q3 2026
- Lionhunter Capital Management, LLC 70.05K 股 · $3.37M · Q3 2026
更多关于 Soleus Capital Management, L.P.
常见问题
How long has Soleus Capital Management, L.P. held RIGL?
Soleus Capital Management, L.P. has disclosed RIGL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Soleus Capital Management, L.P.'s current position in RIGL?
As of Q3 2026, Soleus Capital Management, L.P. holds 1.84M shares of RIGL (RIGEL PHARMACEUTICALS INC), valued at $88.76M, representing 3.16% of its reported portfolio and ranking #7.
Has Soleus Capital Management, L.P. been buying or selling RIGL?
In the latest 13F filing (Q3 2026), Soleus Capital Management, L.P. held unchanged its position in RIGL. The position peaked in Q3 2026 at 1.84M shares.
Which other funds hold RIGL?
Other major institutional holders of RIGL include ARMISTICE CAPITAL, LLC, CM Management, LLC, GLOBEFLEX CAPITAL L P, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.